Skip to main content

Concurrence of familial Mediterranean fever and Behçet’s disease: a case report and review of the literature



Familial Mediterranean fever and Behçet’s disease are distinct disorders that are prevalent in the Mediterranean and Middle Eastern populations. They are characterized by unprovoked inflammatory episodes caused by overexpression of proinflammatory cytokines. Although reported previously, the overlapping presentation of familial Mediterranean fever and Behçet’s disease remains uncommon.

Case presentation

A 46-year-old Lebanese–Canadian man who presented with recurrent oral and genital ulcers, polyarticular synovitis, ocular swelling, recurrent infections, and fevers was later found to have heterozygous mutations of pathogenic MEFV c.2080A > G (p. Met 694Val) and c.2082G > A (p.Met694IIe) genes indicating familial Mediterranean fever. He was treated with prednisone, colchicine, and azathioprine, with inadequate symptoms control. Treatment was complicated by recurrent infections.


Our case contributes to the growing literature demonstrating the presentation of predominantly Behçet’s disease-like features in the setting of diagnosis of familial Mediterranean fever. These findings emphasize that clinicians should be aware that patients with familial Mediterranean fever may present with Behçet’s disease-like clinical manifestations.

Peer Review reports


Familial Mediterranean fever (FMF) is a predominantly autosomal recessive autoinflammatory syndrome that is typically characterized by recurrent fever and serositis [1]. FMF is associated with mutations in the MEFV gene, which encodes the protein pyrin. Pyrin is primarily expressed by polymorphonuclear neutrophils and mature monocytes. It assists in regulating inflammation through enhancing interleukin (IL)-1 responsiveness. FMF mutations in MEFV result in increased inflammatory flares by increasing the activity of the pyrin inflammasome [2,3,4]. Common symptoms on presentation include recurrent fevers, acute peritonitis, monoarticular synovitis, rarely pericarditis, and amyloidosis. The five most common mutations include p.Met694Val, p.Met694Ile, p.Val726Ala, p.Met680IleGC, and p.Glu148Gln [5]. There is geographical variability of mutations, for instance, p.Met694Val and p.Met694Ile were found to be the most common mutations in Jordan and Lebanon in one study [6]. The p.Met694Val mutation, particularly when homozygous, has been associated with the development of amyloidosis and more severe disease [7].

Behçet’s disease is a variable-sized vessel vasculitic disease of unknown etiology, characterized by oral and genital aphthae, relapsing uveitis, and various skin eruptions [9]. Similar to FMF, it is predominant in the Middle Eastern and Mediterranean populations. Increased frequency of MEFV mutations compared with populations known to be rich in Behçet’s disease has been demonstrated [1], suggesting that MEFV may confer susceptibility to Behçet’s disease. In this paper, we describe a case of FMF presented with features of Behçet’s disease.

Case report

A 47-year-old, Lebanese–Canadian male with a chronic history of recurrent skin and soft tissue infection requiring intravenous antibiotics, and recurrent pneumonias in the past several months without history of underlying lung disease was referred to the immunodeficiency/infectious disease clinic for immunodeficiency workup. The patient endorsed a remote history concerning systemic immune disease for cyclic fevers with fatigue, chronic otitis media, polyarthritis, recurrent abdominal pain, and aphthous stomatitis (Table 1). These symptoms stopped spontaneously during puberty at approximately age 15 years, at which point they were replaced by a constellation of acneiform rash on his face that recurs annually, daily headaches with inconclusive investigations including negative electroencephalography, and alopecia areata. At age 42 years, his prior symptoms relapsed, with onset of cyclic fevers with fatigue, polyarthritis, aphthous and genital ulcers, and recurrent infections. His infections consisted of pneumonia, chronic otitis media, and mastoiditis. The aphthous stomatitis was initially thought to be caused by dental abscesses; however, they persisted despite total teeth removal. Interestingly, a swab of the ulcer was positive for herpes simplex virus (HSV)-1 deoxyribonucleic acid on one occasion. He also developed intermittent blurry vision of both eyes, assessed by an ophthalmologist who gave a diagnosis of uveitis. At age 47 years, he began to have chest and abdominal pain associated with his intermittent fevers. There was no relevant psychosocial history.

Table 1 Timeline of symptomatic presentation

Splenomegaly was noted on a CT scan of abdomen and pelvis. Laboratory tests revealed maintained antibody titers to measles, mumps, rubella, diphtheria and tetanus; normal levels of immunoglobulin (Ig)G, IgA, and IgM including IgG subclasses; normal T and B cell counts; normal bone marrow (BM) biopsy; and normal complement function, CH50. He had a slightly positive antinuclear antibodies (ANA) (1:80) with no other positive serology. His blood tests also revealed very low vitamin D level and he was treated for microelement deficiencies that may explain his recurrent infections. It was felt that his presentation was in keeping with probable Behçet’s disease, although it was recognized by the clinical team that he did not meet complete diagnostic criteria for Behçet’s disease. HLA-B51 status was not available.

The patient reported that his mother was diagnosed with Behçet’s disease due to chronic mouth sores, upper arm ulcers and abdominal pain. Notably, his sister also endorses chronic ulcers and arthralgias and his 11-year-old son had developed alopecia. He was subsequently referred for gene panel testing for inborn error of immunity due to strong familial phenotypes. Genetic testing revealed heterozygous mutations of pathogenic MEFV c.2080A > G (p. Met 694Val) and c.2082G > A (p.Met694IIe) genes. This confirmed the genetic diagnosis of FMF syndrome. Anti-IL-1 blocker was considered as the next therapeutic agent; however, treatment initiation was limited by recurrent infection. He has been restarted on colchicine in the interim. His children were also referred for genetic analysis.

The diagnosis of FMF can be made based on clinical symptoms and supported by genetic testing. There have been several proposed diagnostic criteria [11, 12]; however, the most widely accepted is the Tel-HaShomer criteria, which was further simplified by Livneh et al. [13, 14] (Table 2). Our patient was diagnosed with FMF based on the Livneh et al. criteria, in that he satisfies at least two minor criteria for incomplete attacks. He also meets five supportive criteria, including appropriate ethnic origin, age < 20 years at disease onset, severe attacks requiring bed rest, spontaneous remission of attacks, and symptom-free interval. His diagnosis is also supported by the presence of pathogenic mutations.

Table 2 Diagnostic criteria of familial Mediterranean fever adapted from Livneh et al.

Supportive criteria include family history of FMF, appropriate ethnic origin, age < 20 years at disease onset, features of attacks including requiring bed rest due to severity, spontaneous remission, symptom-free interval, transient inflammatory response, episodic proteinuria/hematuria, unproductive laparotomy or removal of appendix, consanguinity of parents. Diagnosis with ≥ 1 major criteria, or ≥ 2 minor criteria, or 1 minor criterion plus ≥ 5 supportive criteria, or 1 minor criterion plus ≥ 4 of the first 5 supportive criteria [14].

In accordance with the International Criteria for Behçet Disease (ICBD), the patients symptoms place him in the category of definitive diagnosis of Behçet’s disease with a score of at least four for oral and genital ulcers [15]. Uveitis is also known to be a significant predictor of Behçet’s disease [15]. As such, this patient has both clinical diagnoses of FMF and Behcet’s disease. Notably, body mass index (BMI) > 30 kg/m2 has previously been found to be independently associated with incidence of Behcet’s disease [16]. However, the patient’s BMI (21.5 kg/m2) was not felt to be contributory. He also did not experience any nonclinical-related challenges during the diagnostic process.

The patient first underwent a trial of colchicine 0.6 mg twice daily for 1.5 months with mild improvement of joint pain only. His fevers were transiently mitigated with high-dose oral prednisone however returned when dose of prednisone was reduced below 20 mg daily. This was discontinued following two subsequent episodes of pneumonia. He was subsequently treated with azathioprine 100 mg daily for 3 months with a decrease of aphthous stomatitis; however, it was ineffective at reducing fevers or joint pain. An anti-IL-1 blocker anakinra was considered as the next therapeutic agent; however, treatment initiation is limited by recurrent infection.

He has been restarted on colchicine 0.6 mg three times daily in the interim, which the patient has yet to begin. At the time of this case report, the patient continues to have acute on chronic otitis media and mastoiditis requiring Port-a-cath for regular intravenous antibiotics. He also continues to have twice weekly fevers, headaches, blurry vision, and joint pain. The patient requires approximately 90 tablets of Tylenol-3 to relieve his pain. There is no current evidence of amyloidosis.


FMF and Behçet’s disease may coexist. Dysregulation of innate inflammatory mechanisms is a hallmark of autoinflammatory conditions, resulting in vasculitic inflammation, recurrent fevers, and increased acute phase reactants. Conversely, autoimmune conditions are associated with the presence of autoantibodies and major histocompatibility complex (MHC) alleles that respond to antigen-specific triggers. While FMF is a prototypal inherited autoinflammatory disease thought to result from inappropriate activation of the proinflammatory cytokine IL-1, the classification of Behçet’s disease into one of these categories is not clear [27, 28]. Although Behçet’s disease has not been found to be associated with autoantibodies, it is related to the HLA-B*51 allele of the class I MHC [29], and infectious triggers have been observed [27]. Furthermore, components of the adaptive immune system, including Th1 and Th17 cells, play an important role in the pathogenesis of Behçet’s disease [28]. Nevertheless, the unprovoked inflammatory episodes caused by overexpression of proinflammatory cytokines in Behçet’s disease are characteristics of autoinflammatory conditions [30]. Similar to FMF, there is increased activity of IL-1 \(\beta\) and neutrophils in Behçet’s disease. There is evidence that Behçet’s disease is related to specific autoinflammatory diseases, and particularly FMF [31, 32]. Notably, MEFV mutations have been shown to be increased in patients with Behçet’s disease, most frequently p.Met694Val [33, 34].

Over 70 FMF-associated mutations have been identified in the MEFV gene [36]. Of its ten exons, the majority of these mutations are on exon 2 (p.Glu148Gln) and exon 10, with two mutation “hot spots” at codon 680 (p.Met680IleGC) and 694 (p.Met694Val, p.Met694Ile) (Fig. 1). Our patient had a heterozygous genotype of p.Met 694Val and p.Met694IIe. Met694Val is the most common mutation in prevalent populations, accounting for 20–65% of all cases [5]. Mutations at codon 694 and 680, including p.Met694Val, p.Met694Ile, and p.Met680IleGC, have been shown to result in a relatively more severe disease course in patients carrying homozygous genotypes [36]. As this region forms the SPRY domain of pyrin, this supports the hypothesis that this region is critical to the conservation of pyrin structure [5]. Met694Val, especially when homozygous, has been linked with more frequent development of amyloidosis, earlier age of onset, and increased frequency of arthritis [7, 8]. However, some studies have not found these associations [37, 38]. Although our patient did have an early age of onset of disease, he did not have severe features including amyloidosis nor significant arthritis, which are typically associated with these mutations.

Fig. 1
figure 1

Common MEFV gene mutations

Certainly, epigenetic factors such as increased methylation of MEFV CpG islands have also been implicated in FMF patients [39]. Modifying loci outside of the MEFV gene, including the MHC class I chain-related gene A (MICA) or SAA-1 alpha/alpha alleles, have also been shown to affect age of onset, and risk of developing amyloidosis, respectively, in those with existing MEFV mutations [5]. Finally, significantly decreased mRNA expression has been demonstrated in FMF patients, particularly in carriers of the M694V mutation and more severe disease [40]. Altogether, the molecular mechanisms of FMF pathogenesis are only partially elucidated, and pathogenesis may include a complex combination of protein instability, decreased quantity of gene expression, genetic, and epigenetic factors, as well as MEFV-independent modifiers.

MEFV gene mutations have also been associated with non-FMF inflammatory diseases, including inflammatory bowel disease, rheumatoid arthritis, fibromyalgia syndrome, Behçet’s disease, ulcerative colitis, ankylosing spondylitis, and juvenile idiopathic arthritis [35]. Chiefly, p.Met 694Val, p.Met680IleGC, p.Val726Ala, and inconsistently p.Glu148Gln have been found to occur more often in patients with Behçet’s disease than control populations [1, 41, 42]. Additionally, the silent polymorphism p706 on exon 10 of MEFV was associated with probable Behçet’s disease but not definite Behçet’s disease [1]. The presence of p.Met694Val in our patient correlates with previous literature of coexistence of this mutation in patients with Behçet’s disease. However, p.Met694IIe, though previously reported [41], has not been shown to be significantly elevated in this population.

Although pathogenesis of Behçet’s disease is unclear, PCR and in situ hybridization studies have isolated various viruses in patients with Behçet’s disease, including HSV, varicella zoster virus, cytomegalovirus, Epstein–Barr virus, human herpes virus 6 and 7, hepatitis virus, human immunodeficiency virus, and parvovirus [44]. HSV has been detected in peripheral blood leukocytes, saliva, and genital ulcer biopsy [46]. There are also clinical similarities between ulcers caused by HSV and herpetiform ulcers in Behçet’s disease. An animal model observed Behçet’s disease-like symptoms most commonly including skin ulcers, eye symptoms, hair loss, and genital ulcers in up to half of mice with HSV inoculated to earlobes [47]. However, observation from HSV inoculation in this study is insufficient to explain the pathogenesis of Behçet’s disease [47]. Several studies have also implicated HSV in the etiology of Behçet’s disease; however, it remains unclear whether the virus itself or a secondary immunological reaction may contribute to the pathogenesis [48]. Interestingly, HSV was identified from an oral ulcer in our case. HSV might have some implication on our patient’s clinical presentation of Behçet’s disease-like features and with the relapse of cyclic fevers and polyarticular arthritis again at age of 42 years.

To investigate whether FMF and Behcet disease coexist, a literature review was performed. We searched relevant articles using the words “Familial Mediterranean fever and Behçet’s disease; FMF; Familial Mediterranean fever syndrome; Behçet’s disease” from 1980 to 2022 in English language on the PubMed database [17,18,19,20,21,22,23,24,25,26].

Nine case reports were identified (Table 3). Only two reported cases did not present with abdominal pain; however, it is unclear whether there was a relevant remote history in these cases [24, 25]. The timing of symptoms differ from our patient, chiefly in the remission of several symptoms following puberty and subsequent relapse in later age. No specific bacteria was identified in the onset of his symptoms, although HSV-1 was confirmed from an oral ulcer. Only one report commented on concomitant occurrence of hydatid disease during symptom flare [23]. No reports thus far have implicated a specific organism in the pathogenesis of triggering Behçet’s disease in patients with FMF. When genetic testing was completed, reported MEFV mutations were discrepant and included Met693Lys, Met694Val, and Glu148Gln, as well as the compound heterozygous mutations Met694Val/Arg202Gln, Glu148Gln/Pro369Ser, and Glu148Gln/Met694Val. Only one patient was HLA-B51 positive [21]. In all cases, colchicine was trialed, and was a component of improved symptoms in the majority of reported patients. Colchicine was used in combination with a variety of anti-inflammatory therapies including steroids, nonsteroidal anti-inflammatory drugs (NSAIDs), sulfasalazine, azathioprine, and methotrexate. In one patient in whom the above combinations were unsuccessful, symptom improvement was achieved with the addition of the IL-1 inhibitor anakinra [25].

Table 3 Summary of case reports with overlap of familial Mediterranean fever and Behçet’s disease [17,18,19,20,21,22,23,24,25,26]

Evidence of a true association between FMF and Behçet’s disease is still lacking. In a retrospective analysis of the medical and genetic records of 2000 patients in Turkey [43], comorbidities in FMF were assessed and categorized as comorbidities directly related to FMF, comorbidities due to increased innate inflammation, and comorbidities that were regarded as being incidental. Within the category of diseases due to increased innate inflammation, the most prevalent comorbid diseases included ankylosing spondylitis (155 patients), juvenile idiopathic arthritis (31 patients), and IgA vasculitis (25 patients). Behçet’s disease was only associated with FMF in 3 of 2000 patients, which is not higher than the prevalence in the population of Turkey. In contrast, an earlier retrospective analysis of 4000 patients with FMF in Israel found that 16 patients also had Behçet’s disease [49]. As these patients had a kin with either Behçet’s disease or FMF, it was suggested that two distinct diseases occurred at once, rather than one disease with additional manifestations. One noted limitation of this study was the predominance of pediatric patients, in whom the prevalence of Behçet’s disease is known to be lower. However, as the prevalence of Behçet’s disease in Israel was not known, an incidental occurrence could not be ruled out. The prevalence of HLA-B*51 in this population was also lower than previously reported prevalence in geographically similar patients with Behçet’s disease. Even so, as the prevalence in this study was greater than those previously reported in countries with a high prevalence of Behçet’s disease, the authors concluded that Behçet’s disease should be included in vasculitides associated with FMF. Furthermore, in a more recent cross-sectional study of 892 adult patients with Behçet’s disease and their age and sex matched controls in Israel, diagnosis of Behçet’s disease was found to be independently associated with FMF on multivariate analysis (OR 25.16, 95% CI 13–53.3) [32]. As well, the association was found to be predominant in females, people of Arab descent, and those with BMI > 30 kg/m2.

Other rare diseases should be considered in the differential of Behçet’s disease and FMF. For instance, A20 haploinsufficiency is caused by mutations in the TNFAIP3, and is an auto-inflammatory disease mediated by the NFkB pathway with many clinical similarities to Behçet’s disease; however, it is typically juvenile onset with excess production of proinflammatory cytokines during flares [50, 51]. Unfortunately, whole-genome sequencing is required to identify such variants, which was not available for our patient.


Several common FMF related MEFV mutations have been associated with Behçet’s disease. As well, Behçet’s disease has been observed to occur more frequently in patients with FMF compared with the general population. It is unclear, however, whether this association is attributable to generalized increased innate immune response in FMF or true shared pathogenesis. Although reported previously, the overlapping presentation of FMF and Behçet’s disease remains uncommon. Nine case reports were found on the coexistence of the FMF and Behçet’s disease. Previous literature has implicated HSV in the etiology of Behçet’s disease and HSV was identified in our patient, which differs from reported cases of Behçet’s disease in patients with FMF. While similar patents have shown symptomatic improvement with colchicine and adjunctive anti-inflamatory therapies, this remains to be seen in our patient. Our case contributes to the growing literature demonstrating the presentation of predominantly Behçet’s disease-like features in the setting of diagnosis of FMF. These findings emphasize that clinicians should be aware that patients with FMF may present with Behçet’s disease-like clinical manifestations.

Availability of data and materials

Not applicable.


  1. Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol. 2017.

    Article  PubMed  Google Scholar 

  2. Chae JJ, Wood G, Masters SL, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA. 2006.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell. 2014.

    Article  Google Scholar 

  4. Onen F. Familial Mediterranean fever. Rheumatol Int. 2006.

    Article  PubMed  Google Scholar 

  5. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001.

    Article  PubMed  Google Scholar 

  6. Medlej-Hashim M, Serre JL, Corbani S, et al. Familial Mediterranean fever (FMF) in Lebanon and Jordan: a population genetics study and report of three novel mutations. Eur J Med Genet. 2005.

    Article  PubMed  Google Scholar 

  7. Delibas A, Oner A, Balci B, et al. Genetic risk factors of amyloidogenesis in familial Mediterranean fever. Am J Nephrol. 2005.

    Article  PubMed  Google Scholar 

  8. Shohat M, Halpern G. Familial Mediterranean fever—a review. Genet Med. 2011.

    Article  PubMed  Google Scholar 

  9. Nair JR, Moots RJ. Behcet’s disease. Clin Med (London England). 2017.

    Article  Google Scholar 

  10. Touitou I, Magne X, Molinari N, Navarro A, Quellec AL, Picco P, Seri M, Ozen S, Bakkaloglu A, Karaduman A, Garnier JM, Demaille J, Koné-Paut I. MEFV mutations in Behçet’s disease. Hum Mutat. 2001.;2-A.

    Article  PubMed  Google Scholar 

  11. Heller H, Sohar E, Sherf L. Familial Mediterranean fever. Arch Intern Med. 1958.

    Article  Google Scholar 

  12. Demirkaya E, Saglam C, Turker T, et al. Performance of different diagnostic criteria for familial Mediterranean fever in children with periodic fevers: results from a multicenter international registry. J Rheumatol. 2016.

    Article  PubMed  Google Scholar 

  13. Bashardoust B. Familial Mediterranean fever; diagnosis, treatment, and complications. J Nephropharmacol. 2015;4(1):5–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M. Criteria for the diagnosis of familial mediterranean fever. Arthritis Rheum. 1997.

    Article  PubMed  Google Scholar 

  15. International Team for the Revision of the International Criteria for Behçet’s D, Davatchi F, Assaad-Khalil S, Calamia KT, Crook JE, Sadeghi-Abdollahi B, Schirmer M, Tzellos T, Zouboulis CC, Akhlagi M, et al. The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014.

  16. Watad A, Tiosano S, Yahav D, Comaneshter D, Shoenfeld Y, Cohen AD, et al. Behçet’s disease‬ and familial Mediterranean fever: Two sides of the same coin or just an association? A cross-sectional study‬ and familial Mediterranean fever: Two

  17. Kiafar M, Faezi ST, Kasaeian A, Baghdadi A, Kakaei S, Mousavi SA, Nejadhosseinian M, Shahram F, Ghodsi SZ, Shams H, Davatchi F. Diagnosis of Behçet’s disease: clinical characteristics, diagnostic criteria, and differential diagnoses. BMC Rheumatol. 2021.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Birlik M, Tunca M, Hizli N, Soyturk M, Yenicerioglu Y, Ozcan MA, El O. Coexistence of familial Mediterranean fever with sacroileitis and Behçet’s disease: a rare occurrence. Clin Rheumatol. 1998;17:397–9.

    Article  CAS  PubMed  Google Scholar 

  19. Zerkaoui M, Laarabi FZ, Ajhoun Y, Chkirate B, Sefiani AA. Novel single variant in the MEFV gene causing Mediterranean fever and Behçet’s disease: a case report. J Med Case Rep. 2018.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Güler T, Garip Y, Dörtbaş F, Karcı AA, Çifçi N. Coexistence of familial Mediterranean fever and Behçet’s disease: a case report. Turk J Physical Med Rehabil. 2017;63(2):174–7.

    Article  Google Scholar 

  21. Sunar I, Sari Surmeli Z, Ozdemirel AE, Yalcin AP, Ataman S. Coexistence of familial Mediterranean fever, Behçet’s disease and sacroiliitis. Arch Rheumatol. 2015.

    Article  Google Scholar 

  22. Mobini M. Familial mediterranean fever in an Iranian patient with behcet disease. Caspian J Intern Med. 2011;2(4):344–6.

    PubMed  PubMed Central  Google Scholar 

  23. Erdem FH, Kartakay S, Melikoglu MA, Senel K. The unusual cause of abdominal pain in a patient with coexistence of Behçet’s disease and familial Mediterranean fever: cyst hydatid disease: case report. Turkiye Klinikleri J Med Sci. 2011;31(1):268–73.

  24. Frigui M, Kechaou M, Jallouli M, Kaddour N, Chaabouni HB, Bahloul Z. Coexistence of Behçet’s disease with ankylosing spondylitis and familial Mediterranean fever: a rare occurrence. Clin Pract. 2011.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Bilginer Y, Ayaz NA, Ozen S. Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease. Clin Rheumatol. 2010;29(2):209–10.

    Article  PubMed  Google Scholar 

  26. Matsuda M, Nakamura A, Tsuchiya S, Yoshida T, Horie S, Ikeda S. Coexistence of familial Mediterranean fever and Behçet’s disease in a Japanese patient. Internal Med (Tokyo, Japan). 2006;45(12):799–800.

    Article  Google Scholar 

  27. Pineton de Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D. New insights into the pathogenesis of Behçet’s disease. Autoimmun Rev. 2012;11(10):687–98.

    Article  CAS  PubMed  Google Scholar 

  28. Hedayatfar A. Behçet’s disease: autoimmune or autoinflammatory? J Ophthalmic Vis Res. 2013;8(3):291–3.

    PubMed  PubMed Central  Google Scholar 

  29. Tong B, Liu X, Xiao J, Su G. Immunopathogenesis of Behcet’s disease. Front Immunol. 2019.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Zhou ZY, Chen SL, Shen N, Lu Y. Cytokines and Behcet’s disease. Autoimmun Rev. 2012;11(10):699–704.

    Article  CAS  PubMed  Google Scholar 

  31. Aksu K, Keser G. Coexistence of vasculitides with familial Mediterranean fever. Rheumatol Int. 2011;31(10):1263–74.

    Article  PubMed  Google Scholar 

  32. Watad A, Tiosano S, Yahav D, Comaneshter D, Shoenfeld Y, Cohen AD, Amital H. Behçet’s disease‬ and familial Mediterranean fever: two sides of the same coin or just an association? A cross-sectional study‬. Eur J Intern Med. 2017;39:75–8.

    Article  PubMed  Google Scholar 

  33. Atagunduz P, Ergun T, Direskeneli H. MEFV mutations are increased in Behcet’s disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol. 2003;21(4 suppl 30):S35–7.

    CAS  PubMed  Google Scholar 

  34. Imirzalioglu N, Dursun A, Tastan B, Soysal Y, Yakicier MC. MEFV gene is a probable susceptibility gene for Behcet’s disease. Scand J Rheumatol. 2005;34:56–8.

    Article  CAS  PubMed  Google Scholar 

  35. Manukyan G, Aminov R. Update on pyrin functions and mechanisms of familial Mediterranean fever. Front Microbiol. 2016.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Shinar Y, Obici L, Aksentijevich I, et al. Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis. 2012;71(10):1599–605.

    Article  CAS  PubMed  Google Scholar 

  37. Yalcinkaya F, Cakar N, Misirlio M, et al. Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology. 2000;39:67072.

    Article  Google Scholar 

  38. Tekin M, Yalcinkaya F, Cakar N, Akar N, Misirliogliu M, Cakar N. MEFV mutations in multiplex families with Familial Mediterranean fever: is a particular genotype necessary for amyloidosis? Clin Genet. 2000;57:430–4.

    Article  CAS  PubMed  Google Scholar 

  39. Kirectepe AK, Kasapcopur O, Arisoy N, Celikyapi Erdem G, Hatemi G, Ozdogan H, Tahir TE. Analysis of MEFV exon methylation and expression patterns in familial Mediterranean fever. BMC Med Genet. 2011;12:105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Notarnicola C, Didelot MN, Koné-Paut I, Seguret F, Demaille J, Touitou I. Reduced MEFV messenger RNA expression in patients with familial Mediterranean fever. Arthritis Rheum. 2002;46(10):2785–93.

    Article  CAS  PubMed  Google Scholar 

  41. Ayesh S, Abu-Rmaileh H, Nassar S, Al-Shareef W, Abu-Libdeh B, Muhanna A, Al-Kafri F. Molecular analysis of MEFV gene mutations among Palestinian patients with Behcet’s disease. Scand J Rheumatol. 2008;37(5):370–4.

    Article  CAS  PubMed  Google Scholar 

  42. Wu Z, Zhang S, Li J, Chen S, Li P, Sun F, Wen X, Zheng W, Zhang F, Li Y. Association between MEFV mutations M694V and M680I and Behçet’s disease: C. PLoS ONE. 2015;10(7): e0132704.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Balcı-Peynircioğlu B, Kaya-Akça U, Serap Arıcı Z, Avcı E, et al. Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology. 2000.

    Article  Google Scholar 

  44. Hatemi G, Yazici H. Behet’s syndrome and micro-organisms. Best Pract Res. 2011;25(3):389–406.

    Article  Google Scholar 

  45. Direskeneli H, Direskeneli S. Disease mechanisms. In: Yazici Y, Yazici H, editors. Behcet’s Syndrome. Springer, New York, NY: USA; 2010. p. 243–64.

    Chapter  Google Scholar 

  46. Studd M, McCance DJ, Lehner T. Detection of HSV-1 DNA in patients with Behcet’s syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol. 1991;34(1):39–43.

    Article  CAS  PubMed  Google Scholar 

  47. Sohn S, Lee ES, Lee S. The correlation of MHC haplotype and development of Behcet’s disease-like symptoms induced by herpes simplex virus in several inbred mouse strains. J Dermatol Sci. 2001;26(3):173–81.

    Article  CAS  PubMed  Google Scholar 

  48. Kim DY, Cho S, Choi MJ, Sohn S, Lee ES, Bang D. Immunopathogenic role of herpes simplex virus in Behçet’s Disease. Genet Res Int. 2013.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A. Behçet’s disease in Familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum. 200; 29(5), 286–295.

  50. Kadowaki T, Ohnishi H, Kawamoto N, Hori T, Nishimura K, Kobayashi C, et al. Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders. J Allergy Clin Immunol. 2018;141(4):1485-1488.e11.

    Article  CAS  PubMed  Google Scholar 

  51. Aeschlimann FA, Batu ED, Canna SW, Go E, Gül A, Hoffmann P, et al. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis. 2018;77(5):728–35.

    Article  CAS  PubMed  Google Scholar 

Download references


Not applicable.


There is no funding received for this case report and review.

Author information

Authors and Affiliations



JC conceptualized the study, provided supervision, and edited the manuscript. AM collected data, performed literature review, and wrote the first draft. CI critically reviewed the manuscript. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Juthaporn Cowan.

Ethics declarations

Ethics approve and consent to participate

Patient consent was obtained for inclusion in our case report. Ethics approval was not required for this review.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors have no competing interests to declare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mir, A., Ivory, C. & Cowan, J. Concurrence of familial Mediterranean fever and Behçet’s disease: a case report and review of the literature. J Med Case Reports 17, 438 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: